The latest news effecting cancer patients and oncology service delivery during the COVID-19 pandemic
An international team of clinicians and researchers for the first time have described the pathology of the SARS-CoV-2, or coronavirus, and published their findings in the Journal of Thoracic Oncology, the journal of the International Association for the Study of Lung Cancer. The article’s senior author, Shu-Yuan Xiao, M.D., from the University of Chicago Medicine in Chicago, USA, teamed up with a small group of clinicians from the Zhongnan Hospital of Wuhan University, in Wuhan, China. “This is the first study to describe the pathology of disease caused by SARS-CoV-2, or COVID-19 pneumonina, since no autopsy or biopsies had been performed…